These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 15830106)
1. [Mechanism of advanced glycation end products-induced hyperpermeability in endothelial cells]. Guo XH; Huang QB; Chen B; Wang SY; Hou FF; Fu N Sheng Li Xue Bao; 2005 Apr; 57(2):205-10. PubMed ID: 15830106 [TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products induce actin rearrangement and subsequent hyperpermeability of endothelial cells. Guo XH; Huang QB; Chen B; Wang SY; Li Q; Zhu YJ; Hou FF; Fu N; Brunk UT; Zhao M APMIS; 2006 Dec; 114(12):874-83. PubMed ID: 17207088 [TBL] [Abstract][Full Text] [Related]
3. [Advanced glycation end products inhibit production of nitric oxide by human endothelial cells through activation of the p38 signal pathway]. Guo Z; Hou F; Zhang X; Liu Z; Wang L Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1328-31. PubMed ID: 12509937 [TBL] [Abstract][Full Text] [Related]
4. Actin cytoskeletal rearrangement and dysfunction due to activation of the receptor for advanced glycation end products is inhibited by thymosin beta 4. Kim S; Kwon J J Physiol; 2015 Apr; 593(8):1873-86. PubMed ID: 25640761 [TBL] [Abstract][Full Text] [Related]
5. Mdia1 is Crucial for Advanced Glycation End Product-Induced Endothelial Hyperpermeability. Zhou X; Weng J; Xu J; Xu Q; Wang W; Zhang W; Huang Q; Guo X Cell Physiol Biochem; 2018; 45(4):1717-1730. PubMed ID: 29490301 [TBL] [Abstract][Full Text] [Related]
6. Role of myosin light chain and myosin light chain kinase in advanced glycation end product-induced endothelial hyperpermeability in vitro and in vivo. Wu F; Guo X; Xu J; Wang W; Li B; Huang Q; Su L; Xu Q Diab Vasc Dis Res; 2016 Mar; 13(2):137-44. PubMed ID: 26607798 [TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end products increase endothelial permeability through the RAGE/Rho signaling pathway. Hirose A; Tanikawa T; Mori H; Okada Y; Tanaka Y FEBS Lett; 2010 Jan; 584(1):61-6. PubMed ID: 19944695 [TBL] [Abstract][Full Text] [Related]
8. Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cells. Higashimoto Y; Matsui T; Nishino Y; Taira J; Inoue H; Takeuchi M; Yamagishi S Microvasc Res; 2013 Nov; 90():64-70. PubMed ID: 24012635 [TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end products induce moesin phosphorylation in murine retinal endothelium. Wang L; Li Q; Du J; Chen B; Li Q; Huang X; Guo X; Huang Q Acta Diabetol; 2012 Feb; 49(1):47-55. PubMed ID: 21327982 [TBL] [Abstract][Full Text] [Related]
11. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. Wautier JL; Zoukourian C; Chappey O; Wautier MP; Guillausseau PJ; Cao R; Hori O; Stern D; Schmidt AM J Clin Invest; 1996 Jan; 97(1):238-43. PubMed ID: 8550841 [TBL] [Abstract][Full Text] [Related]
12. The protective effect of Smilax glabra extract on advanced glycation end products-induced endothelial dysfunction in HUVECs via RAGE-ERK1/2-NF-κB pathway. Sang HQ; Gu JF; Yuan JR; Zhang MH; Jia XB; Feng L J Ethnopharmacol; 2014 Aug; 155(1):785-95. PubMed ID: 24953033 [TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways. Sun C; Liang C; Ren Y; Zhen Y; He Z; Wang H; Tan H; Pan X; Wu Z Basic Res Cardiol; 2009 Jan; 104(1):42-9. PubMed ID: 18622638 [TBL] [Abstract][Full Text] [Related]
14. [Proliferation-inhibiting effect of advanced glycation end products modified human serum albumin to vascular endothelial cell ECV304]. Lin WD; Lu SL; Qing C; Yao M; Chen XF; Xiang J; Qiao L; Liu YK; Dong JY; Shi GY; Liao ZJ; Shi JX Zhonghua Yi Xue Za Zhi; 2003 Apr; 83(7):572-6. PubMed ID: 12887747 [TBL] [Abstract][Full Text] [Related]
15. [Effects of Rho/ROCK signal pathway on AGEs-induced morphological and functional changes in human dermal microvascular endothelial cells.]. Wang JP; Guo XH; Wang LJ; Li Q; Chen B; Wu W; Huang XL; Huang QB Sheng Li Xue Bao; 2009 Apr; 61(2):132-8. PubMed ID: 19377824 [TBL] [Abstract][Full Text] [Related]
16. [Advanced glycation end products stimulate human endothelial cells to produce monocyte chemoattractant protein-1]. Guo ZJ; Hou FF; Liang M; Wang L; Zhang X; Liu ZQ Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(12):1075-9. PubMed ID: 12899782 [TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK. Tanikawa T; Okada Y; Tanikawa R; Tanaka Y J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577 [TBL] [Abstract][Full Text] [Related]
18. Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products. Valencia JV; Mone M; Koehne C; Rediske J; Hughes TE Diabetologia; 2004 May; 47(5):844-52. PubMed ID: 15127201 [TBL] [Abstract][Full Text] [Related]
19. Role of Src in Vascular Hyperpermeability Induced by Advanced Glycation End Products. Zhang W; Xu Q; Wu J; Zhou X; Weng J; Xu J; Wang W; Huang Q; Guo X Sci Rep; 2015 Sep; 5():14090. PubMed ID: 26381822 [TBL] [Abstract][Full Text] [Related]
20. ERM protein moesin is phosphorylated by advanced glycation end products and modulates endothelial permeability. Guo X; Wang L; Chen B; Li Q; Wang J; Zhao M; Wu W; Zhu P; Huang X; Huang Q Am J Physiol Heart Circ Physiol; 2009 Jul; 297(1):H238-46. PubMed ID: 19395553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]